Primary Site >> Liver Cancer
Gene >> CCR6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Liver metastasis of cancer facilitated by chemokine receptor CCR6. PMID: 12791091 |
Ref: Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma. PMID: 15180734 |
Ref: Chemokine receptors support infiltration of lymphocyte subpopulations in human hepatocellular carcinoma. PMID: 15639651 |
Ref: Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma. PMID: 16764701 Ref: Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases. PMID: 17075975 |
Ref: Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. PMID: 19329213 Ref: The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. PMID: 19480006 |
Ref: Chemokines and hepatocellular carcinoma. PMID: 20397259 |
Ref: Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression. PMID: 21557772 Ref: Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases. PMID: 21912453 Ref: Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis. PMID: 21935436 |
Ref: Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses. PMID: 22615204 Ref: Human Th17 cells in patients with cancer: Friends or foe? PMID: 23243621 |
Ref: Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells. PMID: 23659451 |
Ref: CC chemokine receptor 6 expression predicts poor prognosis in hepatocellular carcinoma. PMID: 24634224 |
Ref: [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma]. PMID: 25877311 |
Ref: CCL20-CCR6 Cytokine Network Facilitate Treg Activity in Advanced Grades and Metastatic Variants of Hepatocellular Carcinoma. PMID: 26331965 Ref: Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview. PMID: 26811629 |
Ref: CCR6(+) B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesis. PMID: 28560063 Ref: Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. PMID: 28674001 |
Ref: Recruitment and significance of Th22 cells and Th17 cells in malignant ascites. PMID: 30250609 Ref: CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer. PMID: 30287142 |